Home › Chronic Kidney Disease › Tennessee
Chronic Kidney Disease clinical trials in Tennessee
14 studies for Chronic Kidney Disease are looking for participants at sites in Tennessee.
Cities in Tennessee
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #4, Chattanooga
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Chattanooga
- Research Site, Knoxville
- Research Site, Knoxville
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Chattanooga
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT07624305Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- University of Tennessee Health Science Center- Le Bonheur Research Center, Memphis
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 21, 2026 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 16, 2026 · NCT07107945Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Southeast Renal Research Institute, Chattanooga
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Morristown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Memphis VA Medical Center, Memphis, TN, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05465044Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Knoxville Kidney Center Pllc, Brentwood
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 21 to 85 · All sexes · Updated May 6, 2026 · NCT04984226Empagliflozin Treatment in Kidney Transplant Recipients
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Apr 21, 2026 · NCT06013865Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Apr 6, 2026 · NCT07385651SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- James Eric Gardner, MD, PC, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06001827Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Jan 29, 2026 · NCT06374277From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.